Cell & Gene Therapy Immuno-Oncology
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
18
NCT06002659
CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)
Phase: Phase 1/2
Role: Collaborator
Start: May 1, 2024
Completion: Dec 30, 2027
Loading map...